Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4782307
Max Phase: Preclinical
Molecular Formula: C29H34N6
Molecular Weight: 466.63
Molecule Type: Unknown
Associated Items:
ID: ALA4782307
Max Phase: Preclinical
Molecular Formula: C29H34N6
Molecular Weight: 466.63
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN(CC[C@H](c1ccccc1)c1cc(N)nc2[nH]nnc12)C12CCC(c3ccccc3)(CC1)CC2
Standard InChI: InChI=1S/C29H34N6/c1-35(29-16-13-28(14-17-29,15-18-29)22-10-6-3-7-11-22)19-12-23(21-8-4-2-5-9-21)24-20-25(30)31-27-26(24)32-34-33-27/h2-11,20,23H,12-19H2,1H3,(H3,30,31,32,33,34)/t23-,28?,29?/m1/s1
Standard InChI Key: MIFXHOUDDLZGRL-XPCYEKABSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 466.63 | Molecular Weight (Monoisotopic): 466.2845 | AlogP: 5.43 | #Rotatable Bonds: 7 |
Polar Surface Area: 83.72 | Molecular Species: BASE | HBA: 5 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 8.30 | CX Basic pKa: 11.01 | CX LogP: 3.83 | CX LogD: 2.93 |
Aromatic Rings: 4 | Heavy Atoms: 35 | QED Weighted: 0.38 | Np Likeness Score: -0.25 |
1. Shaw SA,Vokits BP,Dilger AK,Viet A,Clark CG,Abell LM,Locke GA,Duke G,Kopcho LM,Dongre A,Gao J,Krishnakumar A,Jusuf S,Khan J,Spronk SA,Basso MD,Zhao L,Cantor GH,Onorato JM,Wexler RR,Duclos F,Kick EK. (2020) Discovery and structure activity relationships of 7-benzyl triazolopyridines as stable, selective, and reversible inhibitors of myeloperoxidase., 28 (22): [PMID:33007547] [10.1016/j.bmc.2020.115723] |
Source(1):